Team Julie delivers a remarkable outcome based on leading edge clinical science

January 2023

Rapid advances raise the bar on what can be achieved for patients
Charting the journey over 365 days of living with GBM
Meaningful clinical responses to tovorafenib suggest an important new tool in the Brain Cancer Toolbox
An important and visionary partnership featuring multiple members of Team Julie

December 2022

Neurosurgeon "par excellence" and Biotech entrepreneur
Optimizing Immuno-Oncology treatment by overcoming immune-related Adverse Events (irAEs)
We travel to the wedding of a dear friend's daughter in snowy Vermont
Further Evidence that the Central Hypothesis is gaining traction in cancer immunotherapy
Dr. Iyad Alnahhas (Jefferson University Neuro-Oncology) interviews pediatric brain cancer pioneer Dr. David Gutmann (Washington University - St. Louis…
Chief of Neuro-Oncology, Keck Medicine of USC; Co-Director of the USC Brain Tumor Center

November 2022

Multiple, independent R&D streams and major investor discussions are converging on a set of new models for accelerating brain cancer therapeutics…